Latigo Biotherapeutics Statistics
NASDAQ: LTGOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
13.00-0.24 (-1.81%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Latigo Biotherapeutics by the numbers
Latigo Biotherapeutics has a market capitalization of $861.9 million based on 66.30M shares outstanding. With trailing EPS of $-6.07, Latigo Biotherapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 19.1% below its 50-day average and 27.3% below its 200-day average.
Average daily trading volume is 309.60K shares, or about $4.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
LTGO valuation vs. peer median
| Metric | LTGO | Peer median | Difference |
|---|---|---|---|
| Market cap | $861.89M | $879.04M | -2% |
| Avg. volume | 309.60K | 945.31K | -67% |
Peer median across 8 companies: MTRI, AKTS, PHAR, SVRA, CRVS, MLTX, VSTM, CYRX.
Valuation
- Market cap
- $861.89M
- EPS (TTM)
- $-6.07
- Shares outstanding
- 66.30M
Price and trading
- Previous close
- 13.24
- Open
- 13.22
- Day range
- 11.91 – 13.35
- 52-week range
- 10.24 – 25.93
- Beta
- —
- Volume
- 267.17K
- Average volume
- 309.60K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Dec 3, 2026
Additional statistics
- Market Cap
- 861.89M
- Forward Pe
- -6.22
- Eps
- -6.07
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 25.93
- Week52 Low
- 10.24
- Avg Volume
- 309.60K
- Shares Outstanding
- 66.30M
- Ma50
- 16.07
- Ma200
- 17.89
- Earnings Date
- Dec 3, 2026
- Pct From52w High
- -49.87%
- Pct From52w Low
- 26.95%